Injectable / Weight Loss & GLP-1
AOD-9604
Anti-Obesity Drug Fragment · 5mg
$69 USD per unit · Coming soon · 5mg / 2mL vial
Modified growth hormone fragment targeting lipolysis without affecting blood sugar or growth. A targeted approach to fat metabolism.
Product information
AOD-9604 is a modified fragment of human growth hormone (hGH 176-191) specifically designed to stimulate lipolysis and inhibit lipogenesis without the metabolic side effects of full-length hGH.
Unlike growth hormone, AOD-9604 does not affect IGF-1 levels, blood sugar, or tissue growth, making it a targeted anti-obesity peptide with a favorable safety profile.
Benefits
- Targeted lipolysis stimulation
- Lipogenesis inhibition
- No IGF-1 or glucose effects
- Favorable safety profile
Specifications
- Fill / pack
- 5mg / 2mL vial
- Format
- Injectable
- Serving
- 250-500mcg daily
- Servings per container
- 10-20 doses
- Listed purity
- 99.48%
- Molecular weight / composition
- 1815.08 Da
- Storage
- Refrigerate 2-8°C
Frequently asked questions
How should I store this product?
Refrigerate at 2-8°C. Keep away from direct light. Once reconstituted, use within 30 days.
How long until I see results?
Most users report initial effects within 2-4 weeks, with optimal results typically observed after 8-12 weeks of consistent use. Individual responses vary.
Is a Certificate of Analysis included?
Yes. Every order includes a batch-specific COA with HPLC purity analysis, amino acid sequence verification, and endotoxin testing results.
What injection method is recommended?
Subcutaneous injection is standard. Rotate injection sites. Detailed protocol guidance is available on every product page.
For laboratory and research use only. Not for human consumption.
Browse all peptide bioregulators or the Weight Loss & GLP-1 collection. All formulations.